SecBot SecBot
DEFA14A ·Filed Apr 3, 2026

CVS

CVS HEALTH Corp
NEUTRAL
Impact 4/10
Horizonimmediate Processed7mo ago SEC0001308179-26-000202
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no signs of shareholder activism or governance disputes. The recent board appointment of John Gallina, a former CFO of Elevance Health, suggests a focus on financial and audit expertise. Traders should monitor for any future filings indicating activist involvement or governance challenges, but this proxy indicates stable management control.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$73.24
T+0 close · Apr 3, 2026 · via day close
Latest settled
+43.11%
T+60 · $104.81
Vs SPY
+29.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 6 $73.24entry
  2. T+1 · 7mo ago +5.87%α +5.81% · $77.54
  3. T+5 · 7mo ago +5.70%α +1.56% · $77.41
  4. T+20 · 7mo ago +11.99%α +3.01% · $82.02
  5. T+60 · 5mo ago +43.11%α +29.93% · $104.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CVS Health is holding its 2026 annual shareholder meeting to vote on director elections, auditor ratification, executive compensation, and a shareholder proposal to lower the threshold for shareholder action by written consent. This filing follows the recent addition of John Gallina to the board, indicating continuity in governance.

Key Financial Metrics

Vote
director election
Meeting
2026-05-14

Key Facts

  • Annual meeting scheduled for May 14, 2026, to vote on 13 director nominees, auditor ratification, executive compensation (Say on Pay), and a new incentive plan.
  • Shareholders are asked to vote against a proposal to reduce the threshold for shareholder action by written consent.
  • Recent 8-K filing confirms John Gallina's election to the board on March 19, 2026, as an independent director and member of the Audit Committee.
  • The filing is a standard annual proxy statement with no major governance changes or contentious issues.

Financial Impact

No direct financial impact from this filing. The vote on executive compensation and incentive plans relates to ongoing corporate governance.

governanceexecutive compensation

Risk Factors

  • Potential for future shareholder activism if governance or performance issues arise.
  • Regulatory or compliance risks related to executive compensation disclosures.

Market Snapshot

Exchange
NYSE
Sector
Retail-Drug Stores and Proprietary Stores

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001308179-26-000202
Document: 0001308179-26-000202-index-headers.html0001308179-26-000202
Document: 0001308179-26-000202-index.html0001308179-26-000202
Document: 0001308179-26-000202.txt0001308179-26-000202

Track record

25 reports on CVS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +32.33% at T+60 after the Apr 8, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 13, 20264d ago Court Ruling Neutral 3/10 No price data
  2. Nov 6, 202610d ago Insider Buy Bullish 4/10 Entry $85.25 Now $88.59 +3.92% settles Dec 8
  3. Nov 4, 202612d ago 8-K Neutral 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  4. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  5. Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $92.53 Now $88.59 −4.26% settles Nov 23
  6. Oct 15, 20264w ago Press Release Neutral 2/10 Entry $92.58 to $89.79 Now $88.59 −4.31% ▼ −3.01% −1.11% vs SPY
  7. Sep 30, 20266w ago Press Release Neutral 2/10 Entry $85.20 to $90.33 Now $88.59 +3.98% ▲ +6.02% +5.32% vs SPY
  8. Aug 5, 202614w ago 8-K Bullish 8/10 Entry $99.12 to $97.23 Now $88.59 −10.62% ▼ −1.91% −1.31% vs SPY
  9. Jul 10, 202618w ago Press Release Neutral 2/10 Entry $104.15 to $95.46 Now $88.59 −14.94% ▼ −8.35% −10.77% vs SPY
  10. Jun 29, 202620w ago Court Ruling Bullish 5/10 Entry $103.58 to $107.74 Now $88.59 −14.47% ▲ +4.02% +4.30% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026